Synapse - Works

Results (4297)

First results from the phase III ALTTO trial (BIG 2-06; NCCTG [Alliance] N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T -> L), or their combination (T plus L) in the adjuvant treatment of HER2-positive early breast cancer (EBC)

Meeting Abstract

Piccart-Gebhart, M. J.; Holmes, A. P.; Baselga, J.; de Azambuja, E.; Dueck, A. C.; Viale, G.; Zujewski, J. A.; Goldhirsch, A.; Santillana, S.; Pritchard, K. I.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator's choice of chemotherapy in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL)

Meeting Abstract

Phillips, A. A.; Fields, P.; Hermine, O.; Taylor, G.; DelloukIna, M. L.; Horwitz, S. M.; Ramos, J. C.; Menlane, J. C.; Barta, S. K.; Or, K. M.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

SELECT: A multicenter phase II trial of adjuvant erlotinib in resected early-stage EGFR mutation-positive NSCLC

Meeting Abstract

Pennell, N. A.; Neal, J. W.; Chaft, J. E.; Azzoli, C. G.; Jänne, P. A.; Govindan, R.; Evans, T. L.; Costa, D. B.; Rosovsky, R. P. G.; Wakelee, H. A.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Bevacizumab (BEV) and risk of hemorrhage (HEM) in metastatic castration-resistant prostate cancer (mCRPC) patients treated on CALGB 90401 (ALLIANCE)

Meeting Abstract

Patel, J. N.; Jiang, C.; Hertz, D. L.; Mulkey, F.; Friedman, P. N.; Halabi, S.; Ratain, M. J.; Morris, M. J.; Small, E. J.; Owzar, K.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Outcomes of biliary stents in advanced pancreatic cancer in the era of improved systemic therapy

Meeting Abstract

Park, W.; Mankal, P. K.; O'Reilly, E. M.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

The effects of oncologists' physical activity recommendations and information packages on level of physical activity and the quality of life in cancer survivors

Meeting Abstract

Park, J. H.; Yoon, Y. J.; Lee, C. W.; Lee, J.; Oh, M.; Chae, J.; Park, H.; Chu, S.; Kim, S. I.; Kim, N. K.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Phase I trial of autologous CD19-targeted CAR-modified T cells as consolidation after purine analog-based first-line therapy in patients with previously untreated CLL

Meeting Abstract

Park, J. H.; Riviere, I.; Wang, X. Y.; Bartido, S.; Sadelain, M.; Brentjens, R. J.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

A phase 1b study of combined angiogenesis blockade with nesvacumab, a selective monoclonal antibody (MAb) to angiopoietin-2 (Ang2) and ziv-aflibercept in patients with advanced solid malignancies

Meeting Abstract

Papadopoulos, K. P.; Graham, D. M.; Tolcher, A. W.; Razak, A. R. A.; Patnaik, A.; Bedard, P. L.; Rasco, D. W.; Amaya, A.; Moore, K. N.; Konner, J. A.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

A phase 1b open-label multicenter study of AZD4547 in patients with advanced squamous cell lung cancers: Preliminary antitumor activity and pharmacodynamic data

Meeting Abstract

Paik, P. K.; Shen, R. L.; Ferry, D.; Soria, J. C.; Mathewson, A.; Kilgour, E.; Landers, D.; Frewer, P.; Brooks, N.; André, F.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

T-cell receptor (TCR) DNA deep sequencing to evaluate clonality of tumor-infiltrating lymphocytes (TILs) in early stage breast cancer patients (pts) receiving preoperative cryoablation (cryo) and/or ipilinournab (ipi)

Meeting Abstract

Page, D. B.; Diab, A.; Yuan, J. D.; Dong, Z. W.; Emerson, R.; Robins, H.; Redmond, D.; Zhao, C. J.; Mu, Z. Y.; Wong, P.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save